Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Sulfadiazine, Trimethoprim
Boehringer Ingelheim Ltd
QJ01EW10
Sulfadiazine, Trimethoprim
Expired
Revised: 27 th May 2009 AN: 01739/2008 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Trinacol Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances : Sulfadiazine 200mg Trimethoprim 40mg Chlorocresol 1mg as antimicrobial preservative Sodium Formaldehyde Sulphoxylate dihydrate 1mg as antioxidant For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection A clear yellow aqueous solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES For use in cattle, pigs and dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Trinacol is indicated in the treatment of acute, subacute and chronic conditions of bacterial origin in cattle, pigs and dogs. The therapeutic spectrum includes both Gram-negative and Gram-positive bacteria including _Streptococci, Staphylococci, Actinobacilli, Actinomycae, _ _Salmonella, Pasteurella, Pneumococci, Proteus, E. Coli, Corynebacteria, _ _Vibrio, Bordetella, Brucella, Klebsiellae and Haemophilae._ 4.3 CONTRAINDICATIONS Injections should not be given by routes other than those recommended. Not to be administered intraperitoneally. Do not administer to animals with known sulphonamide sensitivity, severe liver parenchymal damage, or blood dyscrasias. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known 4.5 SPECIAL PRECAUTIONS FOR USE (I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS. Adequate drinking water should be available during the therapeutic effect of the product. (II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Care must be taken to avoid accidental self injection. Revised: 27 th May 2009 AN: 01739/2008 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Anaphylactic shock potentially fatal, has been observed on occasions following administration of potentiated sulphonamide preparations particularly by intravenous route. Veterinary surgeons should be mindful of this possibility during the injection process. For intraven Read the complete document